Regional cerebral oxygen saturation (rSO 2 ) is currently the most used measure in clinical practice to monitor cerebral ischaemia in patients undergoing carotid endarterectomy (CEA). Although end-tidal carbon dioxide (P ET CO 2 ) is known as a factor that influences rSO 2 , the relationship between P ET CO 2 and rSO 2 has not been quantitatively evaluated in patients with severe arteriosclerosis. This study aimed to evaluate the effect of P ET CO 2 on rSO 2 in patients undergoing CEA under general anaesthesia.
Introduction
Carotid endarterectomy (CEA) is a surgical procedure used to prevent stroke in patients with severe carotid stenosis caused by an atherosclerotic plaque [1] . Cross-clamping of the carotid artery is required to remove plaque at the bifurcation of the common carotid, which can lead to neurological derangement induced by impaired cerebral blood flow [2] . Among the various neurological monitoring modalities, near-infrared spectroscopy-based regional cerebral oxygen saturation (rSO 2 ) is mainly used to monitor cerebral ischaemia in clinical practice [3, 4] . In an earlier study, an 11.7% decrease in rSO 2 from the baseline value was set as the cut-off value of neurological derangement under general anaesthesia [5] . Although end-tidal carbon dioxide (P ET CO 2 ) is known as a factor that influences rSO 2 [6] , the relationship between P ET CO 2 and rSO 2 has not been quantitatively evaluated in patients with severe arteriosclerosis.
In a previous study, a time delay was observed between P ET CO 2 and rSO 2 [7] . The turnover model could appropriately describe it between drug concentration and effect [8] . Moreover, the model is best conceptualized when the effect is an endogenous biomarker [8] . Considering rSO 2 as an endogenous substance in the human body, the turnover model can be used to characterize the effect of P ET CO 2 on rSO 2 [7] .
The aim of this study was to quantitatively evaluate the dose-response relationship between P ET CO 2 and rSO 2 using a turnover model in patients undergoing CEA under general anaesthesia.
Materials and methods

Patient population
This clinical trial was approved by the Institutional Review Board of Asan Medical Center and was registered on an international clinical trials registry platform (http://cris.nih.go.kr; KCT0000179). Written informed consent was obtained from all patients. In total, 32 patients undergoing CEA under general anaesthesia were enrolled in this study. The indication for surgery was 70% stenosis of the internal carotid artery for symptomatic patients. Patients were excluded if they had a history of obstructive lung diseases, including asthma and chronic obstructive pulmonary disease. Twodimensional echocardiography and pulmonary function test were performed before surgery to evaluate the patient's physical condition.
Study procedure
All patients fasted for 6-8 h prior to surgery. For continuous blood pressure monitoring, a 20-gauge catheter was inserted into a radial artery. Electrocardiography, pulse oximetry, P ET CO 2 and invasive blood pressure (Datex-Ohmeda S/5, Planar Systems, Inc., Beaverton, OR, USA) were monitored continuously. Throughout the surgery, these data were downloaded to personal computers using RS232C cables. The rSO 2 (INVOS 5100B, Covidien, Boulder, CO, USA) was monitored continuously and downloaded to a personal computer until recovery from anaesthesia. Sensors for rSO 2 were placed on the right and left forehead. The rSO 2 values from the right and left were averaged to evaluate the effect of P ET CO 2 on rSO 2. The target concentrations of propofol and remifentanil were adjusted to maintain bispectral index (Covidien) values of <60 and stable haemodynamics. Systolic blood pressure (SBP) was maintained within the range of the resting values in the general ward, and were specific to each patient. If necessary, vasopressors and antihypertensive drugs were used to titrate the SBP during surgery. Tracheal intubation was performed after administering cisatracurium (0.2 mg kg À1 ). The lungs of the patients were then ventilated with oxygen in air [1:2, fraction of inspired oxygen (FiO 2 ) = 0.47], and the tidal volume and ventilation rate were adjusted to maintain the P ET CO 2 between 25 and 45 mmHg. Neuromuscular blockade was reversed by administering pyridostigmine and glycopyrrolate at the end of surgery.
Method of intervention to change P ET CO 2
The intervention was conducted between skin incision and clamping of the carotid artery. Approximately 5 min after the start of skin incision, the tidal volume and ventilation rate were adjusted so that P ET CO 2 was maintained at 25 mmHg. When P ET CO 2 was maintained at 25 mmHg for more than 3 min, the tidal volume was halved and the ventilation rate was reduced to 2/3, which was maintained until P ET CO 2 reached 45 mmHg. When P ET CO 2 reached 45 mmHg, they were restored to the control values until P ET CO 2 reached 25 mmHg. The time at which the tidal volume and ventilation rate were decreased to raise P ET CO 2 to 45 mmHg was defined as the reference time. The intervention period was set as the time elapsed between the reference time and the time when P ET CO 2 reached 25 mmHg. The intervention period lasted 27.1 ±5.8 min. After the intervention period, P ET CO 2 was maintained between 35 and 45 mmHg until the end of the surgery.
Data selection of P ET CO 2 and rSO 2
The individual data files of P ET CO 2 and rSO 2 were recorded continuously during the intervention period. The P ET CO 2 and rSO 2 values were updated every 10 s and 5 s, respectively. For pharmacodynamic analysis, these data points were selected every 30 s.
Population pharmacodynamic analysis
We observed a slight time delay between the maximum P ET CO 2 value and maximum rSO 2 value (1.8 ±1.5 min). NONMEM VII level 3 (ICON Development Solutions, Ellicott City, MD, USA) was used to fit a turnover model to the data.
where k in is a turnover rate constant, k out is a fractional turnover rate constant, and rSO 2_base is the baseline rSO 2 . H(c) is a stimulation function to explain the relationship between P ET CO 2 and rSO 2 . Within the P ET CO 2 range used in this study, the relationship is known to be linear [7] . H(c) can be expressed as follows [9] :
where slope is a slope factor in the stimulatory effect of P ET CO 2 on the production of the response (rSO 2 ). To normalize the response of rSO 2 to P ET CO 2 and to reduce the number of parameters to be estimated, rSO 2 data were normalized to individual baseline rSO 2 values. Hence, rSO 2_base was set to 1.
Interindividual random variabilities in pharmacodynamic parameters were estimated assuming a log-normal distribution. Diagonal matrices were applied to estimate the various distributions of η, where η represented the interindividual random variability with a mean of zero and a variance of ω 2 . An additive residual error model was applied to the model building. NONMEM computed the minimum objective function value (OFV), a statistical equivalent to the -2 log likelihood of the model. An α level of 0.05, which corresponds to a reduction in the OFV of 3.84 (chi-square distribution, degree of freedom = 1, P < 0.05), was used to distinguish between the hierarchical models [10] . The covariates analysed were the time-invariant age; height; weight; sex (1: male; 0: female); maximal percent decrease in luminal diameter of the ipsilateral or contralateral internal carotid artery; history of hypertension (HTN) or diabetes mellitus (DM; 1: presence; 0: absence); ejection fraction; E/A ratio; forced vital capacity (FVC); volume that has been exhaled at the end of the first second of forced expiration (FEV1); and FEV1/FVC ratio along with time-varying SBP, mean blood pressure (MBP), and categorical data conversion of SBP (1: <90 mmHg; 2: ≥90 mmHg) and MBP (1: <60 mmHg, 2: ≥60 mmHg) during the intervention period. Nonparametric bootstrap analysis helped validate the models internally (fit4NM 3.3.3, EunKyung Lee and Gyu-Jeong Noh; http://cran.r-project.org/ web/packages/fit4NM/index.html; last accessed: March 16, 2011) [11] . Predictive checks were also performed using fit4NM 3.3.3 [11] . Deterministic simulations were performed to characterize the effect of covariates on rSO 2 by using the estimated pharmacodynamic parameters of the final model.
Statistics
Statistical analyses were conducted using R (version 3.3.2; R Foundation for Statistical Computing, Vienna, Austria) or SigmaStat version 3.5 for Windows (Systat Software, Inc, Chicago, IL, USA). Data are expressed as the mean ± standard deviation for normally distributed continuous variables, the median (25-75%) for non-normally distributed continuous variables, or counts and percentages for categorical variables.
Results
Of the 32 patients enrolled, two were excluded from the analysis because of a technical error in data file storage. The characteristics of the remaining 30 patients are summarized in Table 1 . In total, 1651 rSO 2 data points were used to determine the pharmacodynamic characteristics. Time courses of the P ET CO 2 , rSO 2 , fractional rSO 2 calculated by dividing rSO 2 by individual baseline rSO 2 values, and SBP during the intervention period are shown in Figure 1 . SBPs during the intervention period ranged between 68 and 178 mmHg. Actual and fractional values of rSO 2 vs.P ET CO 2 are displayed in Figure 2 . As P ET CO 2 increased, the rSO 2 value tended to increase. The turnover model well described the time course of rSO 2 . A history of HTN (1: presence; 0: absence) was a significant covariate for the slope, and it resulted in a greater improvement in the OFV (4.70, P < 0.05, degree of freedom = 1) than did the basic model (number of model parameters = 5). Categorical data conversion of SBP (1: <90 mmHg; 2: ≥90 mmHg) was a significant covariate for the k out , and it resulted in a greater improvement in the OFV (88.43, P < 0.001, degree of freedom = 2) than did the OFV of a pharmacodynamic model that included HTN as a covariate for the slope only (number of model parameters = 6). Population pharmacodynamic parameter estimates, interindividual variability and median parameter values (2.5-97.5%) of the nonparametric bootstrap replicates of the final pharmacodynamic model of fractional rSO 2 are represented in Table 2 . Predictive checks of the final pharmacodynamic model are presented in Figure 3 . In total, 5.4% of the data were distributed outside of the 90% prediction intervals of the predictive check. The simulated response of fractional rSO 2 to P ET CO 2 in a hypothetical patient is depicted in Figure 4 .
Discussion
CEA is a prophylactic treatment to reduce the incidence of stroke in patients who are at risk of stroke from emboli arising from atheromatous plaque in the carotid artery [12] . Timely CEA can substantially reduce the risk of stroke, but the possibility of complications during the perioperative period should be also considered. Cerebrovascular accident and myocardial infarction are the two most severe perioperative complications [12] . Especially during surgery, neurological derangement induced by impaired cerebral blood flow usually occurs during cross-clamping of the carotid artery [2] . The primary intervention in this event is the insertion of a shunt. It is also appropriate to maintain blood pressure perhaps 20% above the preoperative level to maintain the perfusion pressure across the Circle of Willis [12] . A number of techniques and monitors, such as stump pressure, electroencephalogram, near-infrared spectroscopy and transcranial Doppler, are available to monitor the occurrence of neurological derangement. Near-infrared spectroscopy-based rSO 2 is currently the most used in clinical practice due to its noninvasiveness and ease of use. During cross-clamping of the carotid artery, a 5-6% increase in rSO 2 was observed at P ET CO 2 40-45 mmHg compared with P ET CO 2 30-35 mmHg in unshunted patients [6] , which means that the rSO 2 value is changed by the change of P ET CO 2 . The turnover model presented in this study well explained the relationship between P ET CO 2 and rSO 2 in patients with arteriosclerosis.
In the final pharmacodynamic model, a history of HTN was a significant covariate for the slope factor in the stimulatory effect of P ET CO 2 on rSO 2 . The response of rSO 2 to P ET CO 2 increase was slow in patients with HTN than in those without HTN (see Figure 3 ). This can be explained by the fact that cerebrovascular carbon dioxide reactivity was more impaired in patients with HTN than in normotensive patients [13, 14] . HTN induces changes in cerebrovascular structure and function, such as an increase in the wall/lumen ratio of the vessels and a decrease in the vasoconstrictory and vasodilatory abilities of the cerebral arterioles [14, 15] . Cerebral remodelling caused by HTN is thought to be related to the slow response to P ET CO 2 change.
In the operating room, a SBP of <80 mmHg is generally considered to indicate hypotension, and efforts are made to correct it [16] . Autoregulation of cerebral blood flow refers to the intrinsic ability to maintain a constant perfusion in the face of blood pressure changes [17] . In normal volunteers, the lower limit of autoregulation may be a MBP of 50-55 mmHg [18] . However, in chronic HTN, the limits of autoregulation are shifted toward high blood pressure [17] . Dynamic cerebral autoregulation is impaired in carotid artery stenosis [19] . Taken together, cerebral blood flow may be reduced if SBP is <90 mmHg. Once cerebral blood flow is reduced, the compensatory mechanism to restore it will be activated. The increase in cerebral blood flow caused by the increase in P ET CO 2 will also become large. This hypothesis may be supported by the results of a previous study showing that full restoration of cerebral blood flow to the baseline value was faster in hypocapnia after the step decrease in SBP, while the response was slower in normocapnia and hypercapnia [20] . The results of the final pharmacodynamic model showed that the values of k out were quite different when SBP was set at a cut-off value of 90 mmHg (see Table 2 ). This difference led to a difference in the reaction of rSO 2 to P ET CO 2 (refer to Figure 3) . When a pharmacodynamic model was fitted to the data after a SBP of 90 mmHg or more was divided into two sections based on 140 mmHg, the k out values were similar (90 ≤ SBP < 140 mmHg: k out = 0.423; 140 ≤ SBP: k out = 0.419). Although categorical data conversion of MBP (1: <60 mmHg; 2: ≥60 mmHg) was a significant covariate for k out , the improvement of OFV (79.04) was less than that of SBP (88.43) as a covariate. The control stream of the final The data are expressed as mean ±standard deviation, median (25-75%) or count, as appropriate. ASA PS, American Society of Anesthesiologists Physical Status;E/A ratio, the ratio of peak velocity flow in early diastole (the E wave) to peak velocity flow in late diastole caused by atrial contraction (the A wave); FVC,forced vital capacity; FEV1, volume that has been exhaled at the end of the first second of forced expiration. Antidiabetic drugs: metformine (9), glimepiride (3), vildagliptin (2), gliclazide (1); antihypertensive drugs: amlodipine (7), atenolol (4), hydrochlorothiazide (4), losartan (3), carvedilol (3), valsartan (2), nebivolo (2), spironolactone (1), barnidipine (1), nisoldipine (1); lipid-lowering drugs: atorvastatin (13), rosuvastatin (9), simvastatin (2); Anticoagulation drugs: clopidogrel (14) , warfarin (1), rivaroxaban (1); * rebamipide (mucosal protection, 4), isosorbide mononitrate (treatment of angina pectoris, 3), choline alfoscerate (treatment of Alzheimer's disease and other dementias, 3), tamsulosin (treatment of symptomatic benign prostatic hyperplasia, 2), allopurinol (decrease of uric acid level, 2), celecoxib (nonsteroidal anti-inflammatory drug, 2), ranitidine (decrease of stomach acid production, 1), cilostazol (alleviation of the symptoms of intermittent claudication, 1).
pharmacodynamic model that included a history of HTN and categorical data conversion of SBP are presented in the Appendix. The difference in the reaction of rSO 2 to P ET CO 2 was the largest in a hypothetical patient without HTN whose SBP remained below 90 mmHg (patient A) than in a patient with HTN whose SBP was maintained above 90 mmHg (patient B). Raising P ET CO 2 from 25 to 45 mmHg showed a difference of 16% fractional rSO 2 between patients A and B (1.16-1.06 = 0.16; see Figure 3 ). Because the actual mean value of rSO 2 at the reference time was 55.8, this difference represented a difference of 8.9 in actual rSO 2 value.
In an earlier study, cerebrovascular carbon dioxide reactivity was greatly reduced in patients with severe cerebral vascular disease [21] . The slope factor in the stimulatory effect of EtCO 2 on rSO 2 was about 2-3 times smaller in patients undergoing carotid endarterectomy than in patients from previous studies without cerebrovascular disease [7] . In a previous Figure 1 Time courses of end-tidal carbon dioxide (P ET CO 2 ; A), regional cerebral oxygen saturation (rSO 2 ; B), fractional rSO 2 (C) and systolic blood pressure (D) during an intervention period to change P ET CO 2 in patients undergoing carotid endarterectomy (n = 30). P ET CO 2 is the partial pressure of CO 2 at the end of an exhaled breath. The intervention was conducted between skin incision and clamping of the carotid artery. The time at which the tidal volume and ventilation rate were decreased to raise P ET CO 2 to 45 mmHg was defined as the reference time. The intervention period was set as the time elapsed between the reference time and the time when P ET CO 2 reached 25 mmHg. Fractional rSO 2 was calculated by dividing rSO 2 by the individual baseline rSO 2 values. The baseline rSO 2 value was defined as the rSO 2 value at the reference time Figure 2 Regional cerebral oxygen saturation (rSO 2, A) and fractional rSO 2 (B) vs. end-tidal carbon dioxide (P ET CO 2 ) in patients undergoing carotid endarterectomy (n = 30). P ET CO 2 is the partial pressure of CO 2 at the end of an exhaled breath. The intervention was conducted between skin incision and clamping of the carotid artery. The time at which the tidal volume and ventilation rate were decreased to raise P ET CO 2 to 45 mmHg was defined as the reference time. The intervention period was set as the time elapsed between the reference time and the time when P ET CO 2 reached 25 mmHg. Fractional rSO 2 was calculated by dividing rSO 2 by the individual baseline rSO 2 values. The baseline rSO 2 value was defined as the rSO 2 value at the reference time study, DM was a significant covariate on the slope factor, but not in this study. Although DM was a significant covariate in the previous study, the slope factor was similar regardless of DM (presence of DM: slope factor = 0.011; absence of DM: Table 2 Population pharmacodynamic parameter estimates, inter-individual variability, and median parameter values (2.5-97.5%) of the nonparametric bootstrap replicates of the final pharmacodynamic model of fractional regional cerebral oxygen saturation (rSO 2 A log-normal distribution of interindividual random variability was assumed. Residual random variability was modelled using an additive error model. Nonparametric bootstrap analysis was repeated 2000 times. CV, coefficient of variation; k out , fractional turnover rate constant; RSE, relative standard error = SE/mean×100 (%); SBP, categorical data conversion of systolic blood pressure during the intervention period, and every SBP was assigned a value of 1 (<90 mmHg) or 2 (≥90 mmHg). SBPs during the intervention period ranged between 68 mmHg and 178 mmHg. The intervention was conducted between skin incision and clamping of the carotid artery. The time at which the tidal volume and ventilation rate were decreased to raise end-tidal carbon dioxide (P ET CO 2 ) to 45 mmHg was defined as the reference time. The intervention period was set as the time elapsed between the reference time and the time when P ET CO 2 reached 25 mmHg. rSO 2_base : baseline rSO 2 , rSO 2_base was set to 1 because rSO 2 data were normalized to the individual baseline rSO 2 values. Baseline rSO 2 value was defined as the rSO 2 value at the reference time. Slope: slope factor in the stimulatory effect of P ET CO 2 on the production of the response (fractional rSO 2 ). HTN,hypertension;HTN was assigned a value of 1 (a person diagnosed with HTN) or 0 (a person without HTN).
Figure 3
Predictive checks of the final pharmacodynamic model. A black+ indicates the observed fractional regional cerebral oxygen saturation (rSO 2 ). The solid red line and shaded areas indicate the 50% prediction line and 90% prediction intervals, respectively. Fractional rSO 2 was calculated by dividing rSO 2 by the individual baseline rSO 2 values. Baseline rSO 2 value was defined as the rSO 2 value at the reference time. The time at which the tidal volume and ventilation rate were decreased to raise end-tidal CO 2 to 45 mmHg was defined as the reference time
Figure 4
The simulated response of fractional regional cerebral oxygen saturation (rSO 2 ) to end-tidal carbon dioxide (P ET CO 2 ) in a hypothetical patient. Based on the presence of hypertension and whether the systolic blood pressure (SBP) was above or below 90 mmHg, four different cases were simulated. P ET CO 2 and fractional rSO 2 data from a patient (ID 12) were used for the simulation analysis. SBPs observed during the intervention period ranged between 68 mmHg and 178 mmHg. The intervention was conducted between skin incision and clamping of the carotid artery. The time at which the tidal volume and ventilation rate were decreased to raise P ET CO 2 to 45 mmHg was defined as the reference time. The intervention period was set as the time elapsed between the reference time and the time when P ET CO 2 reached 25 mmHg. Fractional rSO 2 was calculated by dividing rSO 2 by the individual baseline rSO 2 values. The baseline rSO 2 value was defined as the rSO 2 value at the reference time Pharmacodynamic modelling of the effect of P ET CO 2 on rSO 2 slope factor = 0.015) [7] . However, the slope factor of patients without HTN was about twice as large as that of patients with HTN in this study, which may suggest that HTN is a more significant covariate than is DM. Cardiovascular lability is often observed in hypertensive patients undergoing general anaesthesia. These patients are prone to episodes of hypotension and HTN during surgery [22, 23] . These adverse events are especially marked in patients undergoing CEA [12] . An earlier study showed that HTN was seen in 25-58% of patients after CEA and hypotension was seen in 8-10% of patients [24] . This study found that patients with HTN had lower cerebrovascular carbon dioxide reactivity than patients without HTN, which means that the ability to maintain cerebral blood flow is weakened. The decrease in SBP of these patients to <90 mmHg may lead to a decrease in cerebral blood flow. Hence, it is advisable to maintain SBP >90 mmHg in patients with HTN during CEA.
There are several limitations of the model. First, HTN is not well controlled and systolic blood pressure may be excessively high in patients with severe atherosclerosis. Because the model was constructed using limited blood pressure range data, it may not be possible to apply the results when the systolic blood pressure range is exceeded. Second, permissive hypercapnia can be helpful in mechanical ventilation strategies in patients with obstructive pulmonary disease [25] . Changes in P ET CO 2 during surgery may cause harm to patients with obstructive lung disease, so these patients were excluded from the clinical study. This model does not explain cerebrovascular carbon dioxide reactivity in patients with obstructive pulmonary disease. Third, it is not possible to predict change of rSO 2 and occurrence of neurological derangement during cross-clamping of the carotid artery because the model was constructed using data before cross-clamping.
There are also several issues to be considered as limitations of this study. First, cerebral near-infrared spectroscopy measures the relative concentrations of oxyhaemoglobin and deoxyhaemoglobin, not cerebral blood flow. When evaluating cerebrovascular carbon dioxide reactivity, cerebral blood flow is commonly measured using transcranial Doppler [14, 18, 26] . However, it is not widely used in clinical situations because of the small or absent transtemporal windows in some patients and the difficulty in keeping the probe steady [27] . Therefore, rSO 2 is widely used because of its convenience and its validation as a measurement tool to detect cerebral ischaemia during carotid endarterectomy [4] . As previously mentioned, the aim of this study was to quantitatively evaluate the effect of P ET CO 2 on rSO 2 , and not evaluating cerebrovascular carbon dioxide reactivity. We used the concept of cerebral carbon dioxide reactivity when interpreting the results of the pharmacodynamic analysis. The findings of this study are physiologically accountable and consistent with those of previous studies [14, 20, 21] . Second, other factors affecting the dependent variable may not have been considered. Haemoglobin, total bilirubin, and inspired oxygen fraction are known as factors affecting rSO 2 measurement values [6, 28, 29] . This study was conducted between skin incision and cross clamping of the carotid artery, and bleeding loss was negligible during this period. Therefore, haemoglobin levels would not have changed much during the intervention period. Total bilirubin levels were in the normal range in all patients, and the inspired oxygen fraction was kept constant. If both P ET CO 2 and FiO 2 are involved in intervention, it may be difficult to evaluate the sole effect of EtCO 2 on rSO 2 . Because the aim of this study was to evaluate the effect of P ET CO 2 on rSO 2 quantitatively, FiO 2 was fixed at a constant value and P ET CO 2 was changed. In an earlier study that quantitatively analysed the effect of P ET CO 2 on rSO 2 under general anaesthesia, FiO 2 was also fixed to a constant value [7] .
In conclusion, the turnover model well described the change in rSO 2 according to the change in P ET CO 2 . HTN and SBP were significant covariates on the slope factor in the stimulatory effect of EtCO 2 and fractional turnover rate constant, respectively. The presence of HTN attenuates the response of rSO 2 after a change in P ET CO 2 . When cerebral blood flow is in a state of decline caused by the decrease in SBP to <90 mmHg, the response of rSO 2 to P ET CO 2 is increased. In anaesthetic management of patients undergoing carotid endarterectomy under general anaesthesia, it is advisable to maintain systolic blood pressure >90 mmHg in patients with HTN. 
